Abstract
The report covers forecast and analysis for the Skin Antiseptic Products market on a global and regional level. The study provides historic data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints for the Skin Antiseptic Products market along with the impact they have on the demand over the forecast period. Additionally, the report includes the study of opportunities available in the Skin Antiseptic Products market on a global level. In order to give the users of this report a comprehensive view on the Skin Antiseptic Products market we have included competitive landscape and analysis of Porter’s Five Forces model for the market. The study encompasses a market attractiveness analysis, wherein type, formulation, application, and regional segments are benchmarked based on their market size, growth rate and general attractiveness.
Human skin antiseptic medications are used to protect against germs and remove existing microorganisms in their bodies. The process for managing infections is considered a crucial element that keeps people and non-living things free from germs. The products are chemical agents that hinder or obstruct the growth of microorganisms (germs) on the surfaces of the external body. Antiseptics are often referred to as skin disinfectants.
The study provides a decisive view on the Skin Antiseptic Products market by segmenting the market based on treatment type, formulation, end-user and regions. All the segments have been analyzed based on present and future trends and the market is estimated from 2019 to 2025. Based on formulation, the market is segmented into Alcohols, Iodine, Octenidine, Chlorhexidine and Others. Due to increased use of formulation for pre-injection and pre-operative skin preparation, the alcohol segment led the market in 2018. In addition, increasing demand for alcohol base to be used in combination with other formulations, such as iodine and chlorhexidine, is fueling growth in the segment.
Based on type, the market is segmented into solutions, wipes and swab sticks. Due to the high prevalence of HAIs & SSIs and the easy availability of various solutions, solutions were the highest revenue-generating category. Growing recognition and growing applications of antiseptic solutions are expected to drive the segment further in the pre-operation and pre-injection skin preparation.
Based on application, the market is segmented into surgeries and injections. Injection segment led the market in 2018 and is anticipated to witness the fastest growth over the forecast period. This is attributable to the increasing use of injections for extracting fluid from swollen joints for injecting medicines.
The regional segmentation includes the current and forecast demand for North America, Europe, Asia Pacific, Latin America, and Middle East & Africa with its further bifurcation into major countries such as US, Canada, Germany, UK, France, China, Japan, India, GCC countries, Brazil. In 2018, North America dominated the global market and over the forecast period is predicted to dominate the market. One of the major drivers negatively affecting market growth is the increasing number of surgeries being performed. Pre-operative skin planning is one of the most important steps that surgeons have taken before surgery. The market for skin antiseptics products is therefore expected to increase with the rate of surgeries.
Due to higher prevalence of Hospital Acquired Infections (HAIs), lack of hygiene and prevention, and increased use of surgical units and endoscope reprocesses, consumer demand is increasing. In addition, the global industry is experiencing comparatively higher levels of growth due to increased spending on health care, increased incidences of hospital-acquired infectious diseases, and increased knowledge of the need for cleanliness and disinfection in the household. Antiseptic skin is considered a vital part of controlling infection. Antiseptic skin is used to hold the germ-free human and non-living. Antiseptic is a drug used by humans and animals in their bodies to stop germs and kill existing microorganisms. Skin antiseptic helps patients with multiple infections improve overall quality of service and patient care. High prevalence and incidence rates of acquired diseases in hospitals, increased emphasis on hygiene and raised concerns about the spread of infectious diseases in both residential and commercial / industrial / healthcare facilities have resulted in increased patient flow to private clinics and hospitals.
Key players within global Skin Antiseptic Products market include 3M, B.Braun Melsungen AG, BD, EcoLab, Johnson & Johnson, Sage Products LLC and Schulke & Mayr GmbH amongst others.
The report segments global Skin Antiseptic Products market as follows:
Global Skin Antiseptic Products Market: Type Segment Analysis
Solutions
Wipes
Swab Sticks
Global Skin Antiseptic Products Market: Formulation Segment Analysis
Alcohols
Iodine
Octenidine
Chlorhexidine
Others
Global Skin Antiseptic Products Market: Application Segment Analysis
Surgeries
Spinal
Joint
Other
Injections
Spinal
Joint
Other
Global Skin Antiseptic Products Market: Regional Segment Analysis
North America
U.S.
Europe
UK
France
Germany
Asia Pacific
China
Japan
India
Latin America
Brazil
Middle East and Africa